Beckman Coulter/Princeton BioMeditech agreement
In a move that underscores its growing commitment to the market for rapid diagnostic medical test products, Beckman Coulter has entered into a supply relationship with Princeton BioMeditech (PBM). Under the agreement, PBM will supply a wide range of rapid diagnostic tools used at the point of medical care to Beckman Coulter's Primary Care Diagnostics business unit (PCD).
Princeton BioMeditech is a leading innovator and manufacturer of simple and rapid diagnostic products used at the point of care. The company offers more than 70 tests covering fertility management, infectious diseases, cardiac markers, drugs of abuse, cancer markers, environmental and veterinary diagnostics that enable consumers and professionals to improve speed and quality of diagnosis for better patient care.
Don Whitley announces distribution arrangement with Cell Biosciences
All equipment sales activities will pass to Cell Biosciences, with all equipment service and...
$50m donation for new endometriosis research institute
Three generations of the philanthropic Ainsworth family have committed a total of $50 million...
New directory, funding to support WA life science sector
The WA Government has announced an online directory for the state's life science sector, as...
